Stock suspension means that the stock price continues to rise or fall due to certain news or activities, and the stock exchange suspends its trading in the stock market. There is usually a prescribed time for stock suspension. After the reasons for suspension are eliminated, the Exchange will issue a Notice of Resumption of Listing to resume its listing.
There are many reasons for the suspension of Huasheng Medical's shares, mainly the following:
1) When the listed company has important information, such as issuing annual report and interim results express, convening shareholders' meeting, increasing capital and shares, issuing distribution plan, major mergers and acquisitions, investment and equity changes, etc. 2) When the securities regulatory agency believes that the listed company needs to clarify and announce matters that have a significant impact on the company;
3) When a listed company is suspected of violating the rules and needs to be investigated, the length of suspension should depend on the situation.
The Guiding Opinions on Improving the System of Suspension and Resumption of Shares of Listed Companies issued by CSRC further improved the system of suspension and resumption of shares of listed companies.
1) Establish the basic principles of stock suspension and resumption of trading of listed companies, and ensure trading opportunities to the maximum extent.
2) Reduce stock suspension time and enhance market liquidity.
3) Strengthen the information disclosure requirements for stock suspension and resumption, and clarify market expectations.
4) Strengthen the system construction and clarify the corresponding supporting work arrangements. Generally speaking, the stock suspension of listed companies is a necessary measure taken by the stock exchange to safeguard the interests of investors and the fairness and justice of market information disclosure, as well as to supervise and restrain the behavior of listed companies.
Shenzhen Huasheng Medical Technology Co., Ltd. (wisonic) was established in Shenzhen in March 2065438+2003, and its business covers products and business solutions in three aspects: life information support, intelligent ultrasound imaging and cloud medical services. 20 17 Huasheng Medical officially landed on the New Third Board with the stock code "87208 1". "Professional focus, specialty" is Huasheng's long-term product direction. Up to now, Watson products have entered more than 50 countries and regions, and more than 200 tertiary hospitals across the country are users of Watson products.